PVLA — Palvella Therapeutics Inc

Ownership history in MPM BioImpact LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Palvella Therapeutics Inc (PVLA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.46% (2025 Q4)
Avg. % of fund
1.58%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 205,745 +138,322 +205.2% 2.46% $21.5M $104.67
2025 Q3 INITIATED 67,423 — — 0.69% $4.2M $62.69
% of Fund (quarterly)    PVLA price (monthly, adj. close)

Other funds also holding PVLA

As of 2025 Q4 — sorted by position size

Clio Asset Management LLC 7.45% First Light Asset Management, LLC 3Y 7Y 5.67% BVF INC/IL 3Y 7Y 3.1% Frazier Life Sciences Management, L.P. 3Y 2.03% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.91% SUPERSTRING CAPITAL MANAGEMENT LP 1.43% Samsara BioCapital, LLC 3Y 7Y 1.13% Lisanti Capital Growth, LLC 3Y 7Y 1.03% Artia Global Partners LP 3Y 0.88% SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 3Y 7Y 0.85%
← Back to MPM BioImpact LLC Holdings